希望燈TA丨孫惠川教授：晚期肝癌系統(tǒng)治療新格局( 二 )
參考文獻(xiàn)
（上下滑動(dòng)可查看）[1] Finn R S , Qin S , Ikeda M , et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma[J]. New England Journal of Medicine, 2020, 382(20):1894-1905.
[2] ASCO 2020 Poster.
[3] Finn R S, Merle P, Granito A, et al. Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial[J]. J Hepatol, 2018,69(2):353-358.
[4] Li X L , Zhu X D , Xiao N , et al. A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study[J]. Surgery, 2020, 167(6).
本文插圖
【希望燈TA丨孫惠川教授：晚期肝癌系統(tǒng)治療新格局】
推薦閱讀
- 吃什么瘦身又健康呢？
- 拉稀水肚子咕嚕怎么辦
- “白骨精”男人私處有3“怕”
- 健康隱患：辦公室日光燈傷害皮膚
- 想要身體好 健康晚餐少不了
- 婚房里有這種燈注定好景不長(zhǎng)
- 8壞習(xí)慣肌膚亮紅燈
- 財(cái)運(yùn)不旺居然是這物數(shù)量沒(méi)選對(duì)
- 家有病人勿入進(jìn)補(bǔ)誤區(qū)
- 6個(gè)信號(hào) 向身體發(fā)出危險(xiǎn)“信號(hào)燈”